Adrian C. Newland

15.6k total citations
281 papers, 8.1k citations indexed

About

Adrian C. Newland is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Adrian C. Newland has authored 281 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Hematology, 69 papers in Immunology and 68 papers in Molecular Biology. Recurrent topics in Adrian C. Newland's work include Platelet Disorders and Treatments (104 papers), Blood groups and transfusion (67 papers) and Chronic Lymphocytic Leukemia Research (40 papers). Adrian C. Newland is often cited by papers focused on Platelet Disorders and Treatments (104 papers), Blood groups and transfusion (67 papers) and Chronic Lymphocytic Leukemia Research (40 papers). Adrian C. Newland collaborates with scholars based in United Kingdom, United States and Italy. Adrian C. Newland's co-authors include Drew Provan, Stephen M. Kelsey, Li Jia, M. G. Macey, Roberto Stasi, James B. Bussel, Sergio Amadori, Fengting Liu, Marion G. Macey and Mary R. Cahill and has published in prestigious journals such as The Lancet, Blood and The Journal of Immunology.

In The Last Decade

Adrian C. Newland

277 papers receiving 7.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian C. Newland United Kingdom 51 3.9k 1.8k 1.6k 1.3k 1.2k 281 8.1k
Keith R. McCrae United States 56 3.7k 0.9× 2.6k 1.5× 2.1k 1.3× 615 0.5× 1.6k 1.4× 252 10.8k
Giorgina Specchia Italy 48 4.1k 1.0× 2.8k 1.5× 1.1k 0.7× 1.2k 1.0× 2.3k 2.0× 401 10.4k
John Freedman Canada 51 5.7k 1.4× 1.0k 0.6× 2.3k 1.4× 777 0.6× 748 0.6× 226 9.4k
David J. Kuter United States 50 6.6k 1.7× 1.3k 0.7× 910 0.6× 1.1k 0.8× 2.0k 1.7× 214 10.4k
Shinji Nakao Japan 49 3.7k 0.9× 1.4k 0.8× 3.0k 1.8× 490 0.4× 1.2k 1.0× 443 8.4k
Simon Karpatkin United States 55 5.9k 1.5× 1.7k 1.0× 1.3k 0.8× 578 0.5× 1.4k 1.2× 206 9.8k
Rajesh Chopra United Kingdom 48 3.2k 0.8× 2.6k 1.4× 1.7k 1.0× 2.3k 1.8× 1.6k 1.3× 171 8.9k
Robert K. Stuart United States 39 3.4k 0.9× 2.0k 1.1× 931 0.6× 536 0.4× 917 0.8× 198 6.9k
Bruce A. Julian United States 64 3.3k 0.8× 2.3k 1.3× 3.5k 2.2× 2.5k 2.0× 794 0.7× 219 13.6k
Yoshiyuki Niho Japan 49 2.3k 0.6× 2.4k 1.3× 2.9k 1.7× 595 0.5× 822 0.7× 423 9.2k

Countries citing papers authored by Adrian C. Newland

Since Specialization
Citations

This map shows the geographic impact of Adrian C. Newland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian C. Newland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian C. Newland more than expected).

Fields of papers citing papers by Adrian C. Newland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian C. Newland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian C. Newland. The network helps show where Adrian C. Newland may publish in the future.

Co-authorship network of co-authors of Adrian C. Newland

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian C. Newland. A scholar is included among the top collaborators of Adrian C. Newland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian C. Newland. Adrian C. Newland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐López, Tomás José, Adrian C. Newland, & Drew Provan. (2023). Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View. Medicina. 59(4). 815–815. 5 indexed citations
2.
3.
Lee, Eun‐Ju, Marina Beltrami Moreira, Hanny Al‐Samkari, et al.. (2021). SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Blood. 139(10). 1564–1574. 47 indexed citations
4.
Kuter, David J., Adrian C. Newland, Beng H. Chong, et al.. (2017). Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year. Blood. 130. 1055–1055. 1 indexed citations
5.
6.
Kuter, David J., James B. Bussel, Adrian C. Newland, et al.. (2013). Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. British Journal of Haematology. 161(3). 411–423. 203 indexed citations
7.
Hallam, Simon, Drew Provan, & Adrian C. Newland. (2013). Immune thrombocytopenia – what are the new treatment options?. Expert Opinion on Biological Therapy. 13(8). 1173–1185. 14 indexed citations
8.
Liu, Fengting, Samir Agrawal, Zanyar Movasaghi, et al.. (2008). Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood. 112(9). 3835–3846. 72 indexed citations
9.
Stasi, Roberto, Elisa Stipa, Giovanni Del Poeta, et al.. (2006). Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Lara D. Veeken. 45(11). 1432–1436. 163 indexed citations
10.
Newland, Adrian C.. (2004). Careers in pathology. BMJ. 329(7474). s187.2–s190. 1 indexed citations
11.
Allen, Paul & Adrian C. Newland. (2003). Apoptosis Detection by DNA Analysis. Humana Press eBooks. 6. 207–214. 5 indexed citations
12.
Macey, M. G., E Carty, Lee Webb, et al.. (1999). Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. Cytometry. 38(5). 250–255. 69 indexed citations
13.
14.
Jones, Lydia & Adrian C. Newland. (1991). The Management of Relapsed and Refractory Acute Myeloid Leukaemia in Adults. Leukemia & lymphoma. 4(2). 93–98. 5 indexed citations
15.
Kelsey, Stephen M., et al.. (1991). ABSORPTION OF LOW AND THERAPEUTIC DOSES OF FERRIC MALTOL, A NOVEL FERRIC IRON COMPOUND, IN IRON DEFICIENT SUBJECTS USING A SINGLE DOSE IRON ABSORPTION TEST. Journal of Clinical Pharmacy and Therapeutics. 16(2). 117–122. 27 indexed citations
16.
Macey, M. G., Elizabeth Macintyre, & Adrian C. Newland. (1986). Red cell sequestration during high dose intravenous immunoglobulin in idiopathic thrombocytopenic purpura. Annals of Hematology. 53(2). 77–87. 5 indexed citations
17.
Newland, Adrian C., et al.. (1986). Allogeneic bone marrow transplantation for adult leukaemia with soy bean lectin fractionated marrow.. PubMed. 1(1). 31–9. 8 indexed citations
18.
Turner, Michael J., et al.. (1986). Massive splenomegaly in myeloproliferative disorders treated by splenic artery infusion of cytarabine. Clinical & Laboratory Haematology. 8(1). 9–19. 1 indexed citations
19.
Jones, Lydia, Monika Bubel, & Adrian C. Newland. (1985). C1 esterase inhibitor as a possible tumour marker in malignant lymphoma. Clinical & Laboratory Haematology. 7(3). 279–281. 4 indexed citations
20.
Cotter, Finbarr E., D. R. Bainbridge, & Adrian C. Newland. (1983). Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange.. BMJ. 286(6358). 22–22. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith R. McCrae Breakdown of academic impact, for papers by Giorgina Specchia Breakdown of academic impact, for papers by John Freedman Breakdown of academic impact, for papers by David J. Kuter Breakdown of academic impact, for papers by Shinji Nakao Breakdown of academic impact, for papers by Simon Karpatkin Breakdown of academic impact, for papers by Rajesh Chopra Breakdown of academic impact, for papers by Robert K. Stuart Breakdown of academic impact, for papers by Bruce A. Julian Breakdown of academic impact, for papers by Yoshiyuki Niho
Rankless by CCL
2026